Human leukocyte antigen and the allocation of kidneys from cadaver donors in the United Kingdom.
The national scheme currently used for the allocation of cadaver kidneys in the United Kingdom includes factors demonstrated to improve transplant outcome and promote equity in organ allocation. Introduced in 1998, the scheme is based on human leukocyte antigen matching, gives priority to children and highly sensitized patients, and incorporates features to assist transplantation in patients who are difficult to match. The scheme is open and transparent and subject to continuous audit and review to address any inequities in access to transplant that become apparent.
Fuggle
Susan V
SV
United Kingdom Transplant, Fox Den Road, Bristol, United Kingdom. susan.fuggle@nds.ox.ac.uk
Johnson
Rachel J
RJ
Rudge
Christopher J
CJ
Forsythe
John L R
JL
D002102:Cadaver; D002648:Child; D006648:Histocompatibility; D006650:Histocompatibility Testing; D006801:Humans; D008913:Minority Groups; D040841:Resource Allocation; D014019:Tissue Donors; D006113:United Kingdom